Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
Pilot study shows that dapagliflozin 5-mg and 10-mg doses were associated with significant reductions in blood glucose and total daily insulin dose.
Dapagliflozin is a member of the SGLT2 inhibitor class of diabetic medications indicated only for treatment of type 2 diabetes. Dapagliflozin helps reduce blood glucose by inhibiting glucose reabsorption without depending on the insulin and by increasing glycosuria.
An exploratory pilot study suggests that dapagliflozin may have potential as an add-on therapy for treating type 1 diabetes.
http://www.diabetesincontrol.com/ar...potential-of-dapagliflozin-in-type-1-diabetes
Dapagliflozin is a member of the SGLT2 inhibitor class of diabetic medications indicated only for treatment of type 2 diabetes. Dapagliflozin helps reduce blood glucose by inhibiting glucose reabsorption without depending on the insulin and by increasing glycosuria.
An exploratory pilot study suggests that dapagliflozin may have potential as an add-on therapy for treating type 1 diabetes.
http://www.diabetesincontrol.com/ar...potential-of-dapagliflozin-in-type-1-diabetes